# New Needle for Two-Needle Hemodialysis

> **NCT01416896** · PHASE2,PHASE3 · UNKNOWN · sponsor: **Biomedical Enterprises Inc** · enrollment: 70 (estimated)

## Conditions studied

- End Stage Renal Disease

## Interventions

- **PROCEDURE:** Hemodialysis using the standard venous needle
- **PROCEDURE:** Hemodialysis using a new venous needle, the "BME needle"
- **PROCEDURE:** Hemodialysis using a new venous needle, the "BME needle"
- **PROCEDURE:** Hemodialysis using the standard venous needle

## Key facts

- **NCT ID:** NCT01416896
- **Lead sponsor:** Biomedical Enterprises Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2011-08
- **Primary completion:** 2012-09
- **Final completion:** 2012-09
- **Target enrollment:** 70 (ESTIMATED)
- **Last updated:** 2011-08-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01416896

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01416896, "New Needle for Two-Needle Hemodialysis". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT01416896. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*